Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM 2023-01-18 09:52
IASO Bio Raises Nearly $75 Million in Series C1 Funding 2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer 2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs 2023-01-18 00:00
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer 2023-01-17 10:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations 2023-01-10 17:03
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships 2023-01-10 07:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine 2023-01-09 20:00
Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S 2023-01-08 14:17
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US 2023-01-07 17:29
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD 2023-01-06 21:00
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) 2023-01-06 20:25
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism 2023-01-06 18:00
1 41 42 43 44 45 147